Exchange Traded Concepts, LLC Vanda Pharmaceuticals Inc. Transaction History

Exchange Traded Concepts, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 05, 2024	BUY	$3.38 - $4.58 $6,401 - $8,674	1,894 Added 0.81%	235,356 $993,000
Q3 2023 Oct 18, 2023	BUY	$4.28 - $6.57 $999,217 - $1.53 Million	233,462 New	233,462 $1.01 Million
Q4 2022 Jan 17, 2023	BUY	$6.87 - $10.96 $382,995 - $611,009	55,749 New	55,749 $412,000
Q2 2022 Jul 20, 2022	BUY	$9.31 - $11.84 $3,789 - $4,818	407 Added 0.92%	44,657 $487,000
Q1 2022 Apr 26, 2022	BUY	$10.84 - $16.55 $479,670 - $732,337	44,250 New	44,250 $500,000
Q3 2021 Oct 18, 2021	SELL	$15.35 - $21.27 $540,120 - $748,427	-35,187 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$15.71 - $21.51 $47,177 - $64,594	3,003 Added 9.33%	35,187 $757,000
Q1 2021 Apr 20, 2021	SELL	$13.42 - $20.28 $332,977 - $503,187	-24,812 Reduced 43.53%	32,184 $483,000
Q4 2020 Jan 19, 2021	BUY	$9.77 - $13.81 $54,164 - $76,562	5,544 Added 10.78%	56,996 $749,000
Q3 2020 Oct 30, 2020	BUY	$9.32 - $12.02 $328,697 - $423,921	35,268 Added 217.92%	51,452 $497,000
Q2 2020 Jul 15, 2020	BUY	$9.66 - $12.02 $156,337 - $194,531	16,184 New	16,184 $185,000

157

44.9M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.